1st Quarter - Report

JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC

Firm
Client
Income
—
Expenses
$3,340,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

- Issues related to the SUPPORT Act

LobbyistCovered position, as disclosed
AMY PELLEGRINO —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Science/Technology SCI

Issues related to - artificial intelligence - data privacy - cybersecurity - robotics

LobbyistCovered position, as disclosed
LEIF BRIERLEY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Issues related to - OECD proposals on global tax & implementation and/or related Presidential executive orders - corporate tax provisions in TCJA including in 2025 reconciliation bills

LobbyistCovered position, as disclosed
DAVID KAVANAUGH —
RILEY SWINEHART —
KELLY WATERS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Treasury, Dept of

Veterans VET

- Issues related to Veterans Administration and Veterans Health Administration procurement and contracting processes for medical technology

LobbyistCovered position, as disclosed
RILEY SWINEHART —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - H.R. XXXX/ S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, H.R. XXX HELP Copays Act, regarding all provisions - H.R. 2214/ S. XXXX Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation Issues related to - direct to consumer advertising - clinical trial modernization - biosimilars - cardiovascular health - 340B - Heart Recovery Awareness Day & H.Res. 1301, designating February 20th Heart Recovery Awareness Day

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1492 (119th), H.R. 1539 (119th), S. 266 (119th), H.R. 2214 (119th), H.Res. 1301 (119th), S. 864 (119th), S. 832 (119th), H.R. 946 (119th)

Budget/Appropriations BUD

- Issues related to stroke care

LobbyistCovered position, as disclosed
LEIF BRIERLEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Copyright/Patent/Trademark CPT

- S. 1040, Drug Competition Enhancement Act, regarding all provisions - S. 1041, Affordable Prescriptions for Patients Act of 2025, regarding all provisions - S. 1097, Interagency Patent Coordination and Improvement Act of 2025, regarding all provisions Issues related to - intellectual property, including S. 1040, a bill to amend the Federal Trade Commission Act to prohibit product hopping - Medication Affordability and Patent Integrity Act - patent thickets

LobbyistCovered position, as disclosed
DAVID KAVANAUGH —
WENDY SUSSMAN —
RILEY SWINEHART —
TIMOTHY SWOPE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1097 (119th), S. 1041 (119th), S. 1040 (119th)

Law Enforcement/Crime/Criminal Justice LAW

Issues related to - H.R. 1109, the Litigation Transparency Act of 2025, and transparency in domestic third-party litigation funding - the Protecting Our Courts from Foreign Manipulation Act, and transparency in foreign third-party litigation funding

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
RILEY SWINEHART —
KELLY WATERS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1109 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.